53 related articles for article (PubMed ID: 38411683)
1. Protective Effects of Home T2DM Treatment with Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Co-transporter-2 Inhibitors Against Intensive Care Unit Admission and Mortality in the Acute Phase of the COVID-19 Pandemic: A Retrospective Observational Study in Italy.
Monda VM; Voci C; Strollo F; Passaro A; Greco S; Monesi M; Bigoni R; Porcellati F; Piani D; Satta E; Gentile S
Diabetes Ther; 2023 Dec; 14(12):2127-2142. PubMed ID: 37801224
[TBL] [Abstract][Full Text] [Related]
2. Electronic cigarettes for smoking cessation.
Hartmann-Boyce J; McRobbie H; Lindson N; Bullen C; Begh R; Theodoulou A; Notley C; Rigotti NA; Turner T; Butler AR; Fanshawe TR; Hajek P
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010216. PubMed ID: 33913154
[TBL] [Abstract][Full Text] [Related]
3. Electronic cigarettes for smoking cessation.
Hartmann-Boyce J; McRobbie H; Lindson N; Bullen C; Begh R; Theodoulou A; Notley C; Rigotti NA; Turner T; Butler AR; Hajek P
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD010216. PubMed ID: 33052602
[TBL] [Abstract][Full Text] [Related]
4. A population-based cohort defined risk of hyperkalemia after initiating SGLT-2 inhibitors, GLP1 receptor agonists or DPP-4 inhibitors to patients with chronic kidney disease and type 2 diabetes.
Fu EL; Mastrorilli J; Bykov K; Wexler DJ; Cervone A; Lin KJ; Patorno E; Paik JM
Kidney Int; 2024 Mar; 105(3):618-628. PubMed ID: 38101515
[TBL] [Abstract][Full Text] [Related]
5. GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes.
Marfella R; Prattichizzo F; Sardu C; Rambaldi PF; Fumagalli C; Marfella LV; La Grotta R; Frigé C; Pellegrini V; D'Andrea D; Cesaro A; Calabrò P; Pizzi C; Antonicelli R; Ceriello A; Mauro C; Paolisso G
Cardiovasc Diabetol; 2024 Jan; 23(1):10. PubMed ID: 38184582
[TBL] [Abstract][Full Text] [Related]
6. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
; Virani SS; Newby LK; Arnold SV; Bittner V; Brewer LC; Demeter SH; Dixon DL; Fearon WF; Hess B; Johnson HM; Kazi DS; Kolte D; Kumbhani DJ; LoFaso J; Mahtta D; Mark DB; Minissian M; Navar AM; Patel AR; Piano MR; Rodriguez F; Talbot AW; Taqueti VR; Thomas RJ; van Diepen S; Wiggins B; Williams MS
J Am Coll Cardiol; 2023 Aug; 82(9):833-955. PubMed ID: 37480922
[TBL] [Abstract][Full Text] [Related]
7. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
Virani SS; Newby LK; Arnold SV; Bittner V; Brewer LC; Demeter SH; Dixon DL; Fearon WF; Hess B; Johnson HM; Kazi DS; Kolte D; Kumbhani DJ; LoFaso J; Mahtta D; Mark DB; Minissian M; Navar AM; Patel AR; Piano MR; Rodriguez F; Talbot AW; Taqueti VR; Thomas RJ; van Diepen S; Wiggins B; Williams MS;
Circulation; 2023 Aug; 148(9):e9-e119. PubMed ID: 37471501
[TBL] [Abstract][Full Text] [Related]
8. Electronic cigarettes for smoking cessation.
Hartmann-Boyce J; Lindson N; Butler AR; McRobbie H; Bullen C; Begh R; Theodoulou A; Notley C; Rigotti NA; Turner T; Fanshawe TR; Hajek P
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD010216. PubMed ID: 36384212
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Outcomes Among Patients with Type 2 Diabetes Newly Initiated on Sodium-Glucose Cotransporter-2 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, and Other Antidiabetic Medications.
Pineda ED; Liao IC; Godley PJ; Michel JB; Rascati KL
J Manag Care Spec Pharm; 2020 May; 26(5):610-618. PubMed ID: 32347181
[TBL] [Abstract][Full Text] [Related]
10. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
[TBL] [Abstract][Full Text] [Related]
11. Electronic cigarettes for smoking cessation.
Lindson N; Butler AR; McRobbie H; Bullen C; Hajek P; Begh R; Theodoulou A; Notley C; Rigotti NA; Turner T; Livingstone-Banks J; Morris T; Hartmann-Boyce J
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD010216. PubMed ID: 38189560
[TBL] [Abstract][Full Text] [Related]
12. Varenicline versus nicotine replacement therapy for long-term smoking cessation: an observational study using the Clinical Practice Research Datalink.
Davies NM; Taylor AE; Taylor GM; Itani T; Jones T; Martin RM; Munafò MR; Windmeijer F; Thomas KH
Health Technol Assess; 2020 Feb; 24(9):1-46. PubMed ID: 32079557
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular outcomes with GLP-1 receptor agonists vs. SGLT-2 inhibitors in patients with type 2 diabetes.
Nørgaard CH; Starkopf L; Gerds TA; Vestergaard P; Bonde AN; Fosbøl E; Køber L; Wong ND; Torp-Pedersen C; Lee CJ
Eur Heart J Cardiovasc Pharmacother; 2022 Sep; 8(6):549-556. PubMed ID: 34215881
[TBL] [Abstract][Full Text] [Related]
14. Weight Loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide 1 Receptor Agonists.
Ard J; Fitch A; Fruh S; Herman L
Adv Ther; 2021 Jun; 38(6):2821-2839. PubMed ID: 33977495
[TBL] [Abstract][Full Text] [Related]
15. Persistence on Novel Cardioprotective Antihyperglycemic Therapies in the United States.
Nargesi AA; Clark C; Aminorroaya A; Chen L; Liu M; Reddy A; Amodeo S; Oikonomou EK; Suchard MA; McGuire DK; Lin Z; Inzucchi S; Khera R
Am J Cardiol; 2023 Jun; 196():89-98. PubMed ID: 37012183
[TBL] [Abstract][Full Text] [Related]
16. Helping pregnant smokers quit: a multi-centre randomised controlled trial of electronic cigarettes versus nicotine replacement therapy.
Przulj D; Pesola F; Myers Smith K; McRobbie H; Coleman T; Lewis S; Griffith C; Walton R; Whitemore R; Clark M; Ussher M; Sinclair L; Seager E; Cooper S; Bauld L; Naughton F; Sasieni P; Manyonda I; Hajek P
Health Technol Assess; 2023 Jul; 27(13):1-53. PubMed ID: 37840301
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
